Cargando…
Patient research priority setting partnership in human T‐cell lymphotropic virus type I
INTRODUCTION: Human T‐cell lymphotropic virus type 1 (HTLV‐1) is a chronic infection affecting 5–10 million people worldwide. Ten percent develop HTLV‐1‐associated diseases, and 3%–5% develop HTLV‐1‐associated myelopathy (HAM)/tropical spastic paraparesis. Low health‐related quality of life (HRQoL)...
Autores principales: | Adonis, Adine, Russell, Anne‐Marie, Taylor, Graham P., Preston, Melanie, Shields, Alpheus, Strachan, Sue, Young, Sky, Diallo, Haissata, Ashford, Stephen, Cassidy, Elizabeth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632630/ https://www.ncbi.nlm.nih.gov/pubmed/37578191 http://dx.doi.org/10.1111/hex.13848 |
Ejemplares similares
-
Effect of pulsed methylprednisolone on disease severity, viral load and inflammation in patients with human T-lymphotropic virus type 1 associated myelopathy
por: Buell, Kevin, et al.
Publicado: (2015) -
Comparison of walking measures in patients with HTLV-1 Associated Myelopathy
por: Adonis, Adine, et al.
Publicado: (2015) -
Assessing Walking Ability in People with HTLV-1-Associated Myelopathy Using the 10 Meter Timed Walk and the 6 Minute Walk Test
por: Adonis, Adine, et al.
Publicado: (2016) -
UK Research Priorities for Electronic Cigarettes: A James Lind Alliance Priority Setting Partnership
por: Hunter, Abby, et al.
Publicado: (2020) -
Defining Priorities for Future Research: Results of the UK Kidney Transplant Priority Setting Partnership
por: Knight, Simon R., et al.
Publicado: (2016)